Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction | Zendy

Tabassome Simon | Zendy; Soraya Taleb | Zendy; Nicolas Danchin | Zendy; Ludivine Laurans | Zendy; Benoı̂t Rousseau | Zendy; Simon Cattan | Zendy; J M Montély | Zendy; Olivier Dubourg | Zendy; Alain Tedgui | Zendy; Salma Kotti | Zendy; Ziad Mallat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction

Author(s) -

Tabassome Simon,

Soraya Taleb,

Nicolas Danchin,

Ludivine Laurans,

Benoı̂t Rousseau,

Simon Cattan,

J M Montély,

Olivier Dubourg,

Alain Tedgui,

Salma Kotti,

Ziad Mallat

Publication year - 2012

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1093/eurheartj/ehs263

Subject(s) - medicine , myocardial infarction , hazard ratio , cardiology , endothelial activation , prospective cohort study , endothelium , gastroenterology , confidence interval

Interleukin (IL)-17 pathway is being clinically targeted in immune-mediated diseases, most of which are associated with a significant cardiovascular risk. We investigated the relationship between serum levels of IL-17 and the risk of cardiovascular events in patients with acute myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research